Stock Analysis on Net
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

CVS Health Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

CVS Health Corp., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income
Depreciation and amortization
Loss on assets held for sale
Store impairments
Goodwill impairment
Stock-based compensation
Restructuring charges, impairment of long-lived assets
(Gain) loss on sale of subsidiary
Loss on early extinguishment of debt
Deferred income taxes and other noncash items
Accounts receivable, net
Inventories
Other assets
Accounts payable and pharmacy claims and discounts payable
Health care costs payable and other insurance liabilities
Other liabilities
Change in operating assets and liabilities, net of effects from acquisitions
Adjustments required to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Proceeds from sales and maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from sale-leaseback transactions
Acquisitions, net of cash and restricted cash acquired
Proceeds from sale of subsidiaries, net of cash and restricted cash sold
Other
Net cash used in investing activities
Commercial paper borrowings (repayments), net
Proceeds from issuance of short-term loan
Repayment of short-term loan
Net borrowings (repayments) of short-term debt
Proceeds from issuance of long-term debt
Repayments of long-term debt
Derivative settlements
Repurchase of common stock
Dividends paid
Proceeds from exercise of stock options
Payments for taxes related to net share settlement of equity awards
Other
Net cash provided by (used in) financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. CVS Health Corp. net cash provided by operating activities decreased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. CVS Health Corp. net cash used in investing activities increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. CVS Health Corp. net cash provided by (used in) financing activities increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.